ISSN Print 2500–1094
ISSN Online 2542–1204
BIOMEDICAL JOURNAL OF PIROGOV UNIVERSITY (MOSCOW, RUSSIA)
Copyright: © 2025 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
ORIGINAL RESEARCH
Features of intrauterine microbiota in patients with endometrial polyps
About authors
1 Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia
2 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
Correspondence should be addressed: Angelina I. Vanakova
Trubetskaya, 8/2, Moscow, 119991, Russia; moc.liamg@avokanavanilegna
About paper
Author contribution: Dolgushina NV — study concept, design; Vanakova AI — data acquisition, manuscript writing; Goncharuk OD, Muravieva VV — laboratory testing; Denisov PA — statistical analysis, visualization; Muravieva VV, Priputnevich TV — data editing.
Received: 2025-01-21
Accepted: 2025-02-10
Published online: 2025-02-24
|
Fig. 1. Cervical canal microbiota in patients with endometrial polyps (group 1) and the comparison group (group 2) (each cell represents bacterial content of the cervical canal in lg CFU/mL)
Fig. 2. Species richness and taxonomic diversity indices of intrauterine microbiota in patients of the studied groups
Fig. 3. Species diversity of intrauterine microbiota in patients of the studied groups: 1 — group with EPs, 2 — group without EPs
Table 1. Formulae for the species richness and diversity indices
Note: S — species richness (number of species); N — sample size (community size); ni — number of species i bacteria; с — number of species common for two communities; а — number of species in the first community; b — number of species in the second community.
Table 2. Clinical and medical history characteristics of patients
Note: * — Mе (Q25–Q75); * * * — Mе (min–max), Mann–Whitney U test; * * — abs (%), χ2 test; COCs — combined oral contraceptoves; GIT — gastrointestinal tract.
Table 3. Patient complaints
Note: abs (%),χ2 test.
